Home > Insider Trading > Filing (0000950170-24-097135)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1818331	Genedx Holdings Corp.	WGS	Pharmaceutical Preparations (2834)	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
944809	Opko Health, Inc.	4400 Biscayne Blvd. Miami FL 33137		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2024-08-12	59,787	$33.95	2,811,783	No	4	S	Direct
Class A Common Stock	Disposition	2024-08-13	24,987	$34.76	2,786,796	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.16 to $34.90, inclusive. The reporting person undertakes to provide to GeneDx Holding Corp. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.50 to $35.9175, inclusive. The reporting person undertakes to provide to Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.